{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:35:13Z","timestamp":1793208913733,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This review evaluates the role of heart failure (HF) registries in the Nordic countries\u2014Sweden, Denmark, Norway, and Iceland\u2014in the implementation of the European Society of Cardiology's guidelines for guideline-directed medical therapy (GDMT) in heart failure with reduced ejection fraction (HFrEF). It critically examines how these registries facilitate clinical practice and enhance patient outcomes through their design, data collection methods, and the evaluation of key metrics related to GDMT implementation over time. We highlight the nurse-led models adopted by these registries, which emphasize quality benchmarks and feature real-time feedback mechanisms regarding the application of GDMT. Between 2021 and 2024, registry population-weighted estimates revealed significant increases in the utilization of key therapies: mineralocorticoid receptor antagonists rose from 51% to 72%, sodium-glucose co-transporter-2 inhibitors from 20% to 81%, and sacubitril\/valsartan from 22% to 32%. The use of beta-blockers and renin-angiotensin-system inhibitors remained consistently high at 91% and 94%, respectively. These shifts were linked to better treatment outcomes. The findings underscore that HF registries play a crucial role in enhancing care quality through established drug therapies for HFrEF, offering a model for integrating data-driven methodologies into HF management. Future utilization and expansion of these registries are vital for tackling healthcare disparities and refining treatment strategies for HF patients.<\/jats:p>","DOI":"10.1093\/ejhf\/xuag060","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:28:31Z","timestamp":1772540911000},"page":"621-630","source":"Crossref","is-referenced-by-count":2,"title":["Enhancing heart failure care through registries: lessons learned from Nordic Countries\u2019 implementation of guidelines"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-1804","authenticated-orcid":false,"given":"Peder L","family":"Myhre","sequence":"first","affiliation":[{"name":"Department of Cardiology, Division of Medicine, Akershus University Hospital , Sykehusveien 25, 1478 L\u00f8renskog ,","place":["Norway"]},{"name":"Institute of Clinical Medicine, University of Oslo , PO Box 1171\u2014Blindern, Oslo 0318 ,","place":["Norway"]},{"name":"Department of Cardiology, Oslo University Hospital , Sognsvannsveien 20, 0372 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-9877","authenticated-orcid":false,"given":"Felix","family":"Lindberg","sequence":"additional","affiliation":[{"name":"Department of Clinical Science and Education, S\u00f6dersjukhuset; Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian B","family":"L\u00f8gstrup","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aarhus University Hospital , Aarhus ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga J","family":"Ingimarsdottir","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Landsp\u00edtali\u2014The National University Hospital of Iceland , Reykjav\u00edk ,","place":["Iceland"]},{"name":"Department of Health Sciences, Faculty of Medicine, University of Iceland , Reykjav\u00edk ,","place":["Iceland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6243-0626","authenticated-orcid":false,"given":"Maria","family":"Vistnes","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo , PO Box 1171\u2014Blindern, Oslo 0318 ,","place":["Norway"]},{"name":"Department of Cardiology, Oslo University Hospital , Sognsvannsveien 20, 0372 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Schj\u00f8dt","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aarhus University Hospital , Aarhus ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2785-1919","authenticated-orcid":false,"given":"Charlotta","family":"Ljungman","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, University of Gothenburg , G\u00f6teborg ,","place":["Sweden"]},{"name":"Department of Cardiology, Sahlgrenska University Hospital , Goteborg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-0887","authenticated-orcid":false,"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[{"name":"Department of Clinical Science and Education, S\u00f6dersjukhuset; Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia P","family":"Dridi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sj\u00e6llands Universitetshospital , Roskilde ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsteinn","family":"Einarsson","sequence":"additional","affiliation":[{"name":"Department of Computer Science, University of Iceland , Reykjav\u00edk ,","place":["Iceland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9090-6743","authenticated-orcid":false,"given":"Tomas","family":"Mellberg","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, University of Gothenburg , G\u00f6teborg ,","place":["Sweden"]},{"name":"Department of Cardiology, Sahlgrenska University Hospital , Goteborg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Berge","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Division of Medicine, Akershus University Hospital , Sykehusveien 25, 1478 L\u00f8renskog ,","place":["Norway"]},{"name":"Institute of Clinical Medicine, University of Oslo , PO Box 1171\u2014Blindern, Oslo 0318 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8715-7753","authenticated-orcid":false,"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[{"name":"Faculty of Health, Universit\u00e9 Paris Cit\u00e9 , Paris ,","place":["France"]},{"name":"Department of Scientific Research, UMRS 942 MASCOT , Paris ,","place":["France"]},{"name":"Department of Anesthesiology, Burn and Critical Care Medicine, H\u00f4pitaux Universitaires Saint-Louis-Lariboisi\u00e8re, Assistance Publique-H\u00f4pitaux de Paris , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H","family":"Lund","sequence":"additional","affiliation":[{"name":"Unit of Cardiology, Department of Medicine, Karolinska Institutet, and Heart and Vascular and Neuro Theme, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"2026102813045903800_xuag060-B1","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1038\/s41591-023-02567-2","article-title":"Recent successes in heart failure treatment","volume":"29","author":"Lam","year":"2023","journal-title":"Nat Med"},{"key":"2026102813045903800_xuag060-B2","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026102813045903800_xuag060-B3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/03009734.2018.1490831","article-title":"The Swedish heart failure registry: a living, ongoing quality assurance and research in heart failure","volume":"124","author":"Savarese","year":"2019","journal-title":"Ups J Med Sci"},{"key":"2026102813045903800_xuag060-B4","author":"Alfredsson"},{"key":"2026102813045903800_xuag060-B5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2147\/clep.S99504","article-title":"The Danish heart failure registry","volume":"8","author":"Schj\u00f8dt","year":"2016","journal-title":"Clin Epidemiol"},{"key":"2026102813045903800_xuag060-B6","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.2147\/clep.S390898","article-title":"The Danish heart failure registry: a validation study of content","volume":"14","author":"Andersen","year":"2022","journal-title":"Clin Epidemiol"},{"key":"2026102813045903800_xuag060-B7","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1002\/ehf2.15012","article-title":"The Icelandic Heart Failure Registry-A nationwide assessment tool for HF care and intervention in HF treatment","volume":"11","author":"Ingimarsd\u00f3ttir","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2026102813045903800_xuag060-B8","author":"European Uni\ufb01ed Registries for HeartCare Evaluation and Randomised Trials (EuroHeart): EuroHeart Consolidation Phase Planning"},{"key":"2026102813045903800_xuag060-B9","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1002\/ehf2.15337","article-title":"Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF guidelines","volume":"12","author":"Berge","year":"2025","journal-title":"ESC Heart Fail"},{"key":"2026102813045903800_xuag060-B10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ejhf.496","article-title":"Use of evidence-based therapy and survival in heart failure in Sweden 2003\u20132012","volume":"18","author":"Thorvaldsen","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B11","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1002\/ehf2.15320","article-title":"Real-world use of guideline-directed therapy for heart failure: insights from the Danish Heart Failure Registry","volume":"12","author":"Schj\u00f8dt","year":"2025","journal-title":"ESC Heart Fail"},{"key":"2026102813045903800_xuag060-B12","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/ejhf.2971","article-title":"Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: data from the Swedish Heart Failure Registry","volume":"25","author":"Stolfo","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B13","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/ejhf.3295","article-title":"How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the heart failure association of the ESC","volume":"26","author":"Savarese","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ejhf.3506","article-title":"Trends in heart failure mortality in Sweden between 1997 and 2022","volume":"27","author":"Lindberg","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B15","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.1016\/S2666-7568(24)00029-1","article-title":"Age-specific mortality trends in heart failure over 25 years: a retrospective Danish nationwide cohort study","volume":"5","author":"Garred","year":"2024","journal-title":"Lancet Healthy Longev"},{"key":"2026102813045903800_xuag060-B16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/ejhf.762","article-title":"Association between enrolment in a heart failure quality registry and subsequent mortality-a nationwide cohort study","volume":"19","author":"Lund","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B17","doi-asserted-by":"publisher","first-page":"e011737","DOI":"10.1161\/jaha.118.011737","article-title":"Nurse-led heart failure clinics are associated with reduced mortality but not heart failure hospitalization","volume":"8","author":"Savarese","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026102813045903800_xuag060-B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14017431.2020.1820075","article-title":"Reorganization of heart failure management and improved outcome\u2014the 4D HF Project","volume":"55","author":"Matan","year":"2021","journal-title":"Scand Cardiovasc J"},{"key":"2026102813045903800_xuag060-B19","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/europace\/eut416","article-title":"Awareness of indications for device therapy among a broad range of physicians: a survey study","volume":"16","author":"H\u00fcbinette","year":"2014","journal-title":"Europace"},{"key":"2026102813045903800_xuag060-B20","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1093\/eurheartj\/ehaf229","article-title":"Heart failure: the need for cardiologist-guided follow-up to improve outcomes","volume":"46","author":"Lund","year":"2025","journal-title":"Eur Heart J"},{"key":"2026102813045903800_xuag060-B21","doi-asserted-by":"publisher","first-page":"1385281","DOI":"10.3389\/fcvm.2024.1385281","article-title":"The management of heart failure in Sweden-the physician's perspective: a survey","volume":"11","author":"Ferrannini","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"2026102813045903800_xuag060-B22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/ehf2.13848","article-title":"Patient profile and outcomes associated with follow-up in specialty vs. primary care in heart failure","volume":"9","author":"Lindberg","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026102813045903800_xuag060-B23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijcard.2021.09.013","article-title":"Non-cardiology vs. cardiology care of patients with heart failure and reduced ejection fraction is associated with lower use of guideline-based care and higher mortality: observations from The Swedish Heart Failure Registry","volume":"343","author":"Kapelios","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026102813045903800_xuag060-B24","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/ejhf.2338","article-title":"Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry","volume":"23","author":"Becher","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B25","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/ejhf.781","article-title":"Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry","volume":"19","author":"Lund","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B26","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1002\/ejhf.3404","article-title":"Status and timing of angiotensin receptor-neprilysin inhibitor implementation in patients with heart failure and reduced ejection fraction: data from the Swedish Heart Failure Registry","volume":"26","author":"Stolfo","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B27","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1002\/ehf2.12883","article-title":"Implementation of sacubitril\/valsartan in Sweden: clinical characteristics, titration patterns, and determinants","volume":"7","author":"Fu","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026102813045903800_xuag060-B28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/ejhf.3523","article-title":"Discontinuation and reinitiation of mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction","volume":"27","author":"Landucci","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B29","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/s0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"2026102813045903800_xuag060-B30","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026102813045903800_xuag060-B31","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/ejhf.2149","article-title":"Rapid evidence-based sequencing of foundational drugs for heart failure and a reduced ejection fraction","volume":"23","author":"Packer","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B32","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ejhf.2477","article-title":"Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry","volume":"24","author":"D'Amario","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B33","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jacc.2023.02.005","article-title":"Cluster-randomized trial comparing ambulatory decision support tools to improve heart failure care","volume":"81","author":"Mukhopadhyay","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026102813045903800_xuag060-B34","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1038\/s41591-024-03238-6","article-title":"Digital consults in heart failure care: a randomized controlled trial","volume":"30","author":"Man","year":"2024","journal-title":"Nat Med"},{"key":"2026102813045903800_xuag060-B35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/ehjdh\/ztaf062","article-title":"Telemonitored standardized titration for heart failure with reduced ejection fraction, an open clinical cohort study","volume":"6","author":"Louca","year":"2025","journal-title":"Eur Heart J\u2014Digital Health"},{"key":"2026102813045903800_xuag060-B36","doi-asserted-by":"publisher","first-page":"100866","DOI":"10.1016\/j.landig.2025.02.006","article-title":"Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): a multicentre, randomised controlled trial","volume":"7","author":"Yun","year":"2025","journal-title":"Lancet Digit Health"},{"key":"2026102813045903800_xuag060-B37","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/ehjdh\/ztae064","article-title":"Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum","volume":"5","author":"Schuuring","year":"2024","journal-title":"Eur Heart J Digit Health"},{"key":"2026102813045903800_xuag060-B38","doi-asserted-by":"publisher","first-page":"e010158","DOI":"10.1161\/CIRCHEARTFAILURE.122.010158","article-title":"In-hospital virtual peer-to-peer consultation to increase guideline-directed medical therapy for heart failure: a pilot randomized trial","volume":"16","author":"Rao","year":"2023","journal-title":"Circ Heart Fail"},{"key":"2026102813045903800_xuag060-B39","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.jacc.2023.02.029","article-title":"Virtual care team guided management of patients with heart failure during hospitalization","volume":"81","author":"Bhatt","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026102813045903800_xuag060-B40","author":"Socialstyrelsen"},{"key":"2026102813045903800_xuag060-B41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/eurheartj\/ehab751","article-title":"Implementation science and potential for screening in heart failure","volume":"43","author":"Lund","year":"2022","journal-title":"Eur Heart J"},{"key":"2026102813045903800_xuag060-B42","doi-asserted-by":"publisher","first-page":"e755","DOI":"10.1016\/s2589-7500(24)00158-4","article-title":"Digital tools in heart failure: addressing unmet needs","volume":"6","author":"Myhre","year":"2024","journal-title":"Lancet Digit Health"},{"key":"2026102813045903800_xuag060-B43","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/ejhf.70065","article-title":"Global registries and surveys programme\u2013heart failure (GRASP-HF): rationale, study design and research implications","volume":"27","author":"Chioncel","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction","volume":"72","author":"Greene","year":"2018","journal-title":"JACC"},{"key":"2026102813045903800_xuag060-B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","article-title":"Heart failure drug treatment\u2014inertia, titration, and discontinuation","volume":"11","author":"Savarese","year":"2023","journal-title":"JACC Heart Fail"},{"key":"2026102813045903800_xuag060-B46","doi-asserted-by":"publisher","first-page":"e088998","DOI":"10.1136\/bmjopen-2024-088998","article-title":"Temporal trends in guideline-recommended medical therapy after an acute heart failure decompensation event: an observational analysis from Generator Heart Failure DataMart","volume":"15","author":"Laborante","year":"2025","journal-title":"BMJ Open"},{"key":"2026102813045903800_xuag060-B47","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1002\/ejhf.3376","article-title":"European society of cardiology quality indicators update for the care and outcomes of adults with heart failure. The Heart Failure Association of the ESC","volume":"26","author":"Abdin","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B48","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1093\/eurheartj\/ehac151","article-title":"Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)","volume":"43","author":"Aktaa","year":"2022","journal-title":"Eur Heart J"},{"key":"2026102813045903800_xuag060-B49","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1002\/ejhf.3445","article-title":"Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction\u2014the ESC EORP Heart Failure III Registry","volume":"26","author":"Lund","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026102813045903800_xuag060-B50","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/ejhf.3087","article-title":"Rationale and design of the ESC Heart Failure III Registry\u2014implementation and discovery","volume":"25","author":"Lund","year":"2023","journal-title":"Eur J Heart Fail"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag060\/67257646\/xuag060.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/28\/4\/621\/67257646\/xuag060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/28\/4\/621\/67257646\/xuag060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:05:05Z","timestamp":1793207105000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/28\/4\/621\/8509165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,3,5]]},"published-print":{"date-parts":[[2026,10,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ejhf\/xuag060","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,5]]}}}